See more : Coherus BioSciences, Inc. (CHRS) Income Statement Analysis – Financial Results
Complete financial analysis of VG Acquisition Corp. (VGAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of VG Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Wingstop Inc. (WING) Income Statement Analysis – Financial Results
- Jio Financial Services Limited (JIOFIN.NS) Income Statement Analysis – Financial Results
- Comvita Limited (CVT.NZ) Income Statement Analysis – Financial Results
- Central Plaza Hotel Public Company Limited (CENTEL.BK) Income Statement Analysis – Financial Results
- Bank of Cyprus Holdings Public Limited Company (BKCYF) Income Statement Analysis – Financial Results
VG Acquisition Corp. (VGAC)
About VG Acquisition Corp.
VG Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
| Metric | 2020 |
|---|---|
| Revenue | 0.00 |
| Cost of Revenue | 0.00 |
| Gross Profit | 0.00 |
| Gross Profit Ratio | 0.00% |
| Research & Development | 0.00 |
| General & Administrative | 0.00 |
| Selling & Marketing | 0.00 |
| SG&A | 0.00 |
| Other Expenses | -53.73K |
| Operating Expenses | -53.73K |
| Cost & Expenses | -53.73K |
| Interest Income | 0.00 |
| Interest Expense | 0.00 |
| Depreciation & Amortization | 206.30K |
| EBITDA | -53.73K |
| EBITDA Ratio | 0.00% |
| Operating Income | -53.73K |
| Operating Income Ratio | 0.00% |
| Total Other Income/Expenses | 0.00 |
| Income Before Tax | -53.73K |
| Income Before Tax Ratio | 0.00% |
| Income Tax Expense | 0.00 |
| Net Income | -53.73K |
| Net Income Ratio | 0.00% |
| EPS | 0.00 |
| EPS Diluted | 0.00 |
| Weighted Avg Shares Out | 64.66M |
| Weighted Avg Shares Out (Dil) | 64.66M |
New 23andMe to Trade on Nasdaq as "ME"
NEW YORK and SUNNYVALE, Calif., May 26, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC) ("VGAC" and, after the Domestication (as defined below) and following its name change to 23andMe Holding Co., "New 23andMe") today announced that, upon the Domestication and...
Virgin Group's VG Acquisition Corp. Announces Date of Shareholders Meeting in Connection with its Pending Business Combination with 23andMe
NEW YORK and SUNNYVALE, Calif., May 17, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, today announced that the date of its extraordinary general meeting of shareholders to vote on its proposed business...
Virgin Group's VG Acquisition Corp. Filed Amended Form S-4 in Connection with its Pending Business Combination with 23andMe
NEW YORK and SUNNYVALE, Calif., May 5, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, today announced that it has filed an amended registration statement on Form S-4 in connection with...
VG Acquisition Corp.: 23andMe Could Be A Massive But Risky Winner
VG Acquisition Corp.: 23andMe Could Be A Massive But Risky Winner
Top Stocks 2021: If You Only Buy One SPAC Stock, It Better Be Tuscan Holdings
Granted, future projections are not guarantees. But, considering this EV battery company is focusing on the commercial vehicle niche, and the fact it's locked down partnerships with major truck makers like Oshkosh (NYSE:OSK), THCB stock could live up to expectations,...
8 Major Players in the SPAC Game to Watch
With SPACs, you can get in on the ground floor of good -- or bad -- ideas, or you can just bet on the guys holding the checkbook. The post 8 Major Players in the SPAC Game to Watch appeared...
VG Acquisition Stock: The Value's in the DNA Vault, Not the Spit Kits
If 23andme is worth $3.5 billion, it's based on the long-term asset of its DNA database, not the cash it gets from consumers for its saliva testing kits. The post VG Acquisition Stock: The Value's in the DNA Vault, Not...
SPACs to Watch: Lucid Motors, 23andMe, and More
Two of these have identified their targets, and the other has some interesting possibilities.
As 23andMe Flounders, Buying Into VG Acquisition Looks Like a Terrible Idea
VGAC stock will keep losing steam since markets expected an EV of financial services merger target rather than a genetic testing company. The post As 23andMe Flounders, Buying Into VG Acquisition Looks Like a Terrible Idea appeared first on InvestorPlace.
SHAREHOLDER ALERT: WeissLaw LLP Reminds CLGX, VGAC, SNCA, and RNET Shareholders About Its Ongoing Investigations
NEW YORK, March 11, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua...
Source: https://incomestatements.info
Category: Stock Reports